In our study, FGF10 treatment decreased the activity of apoptosis regulators cytochrome c and caspase‐3, and slightly increased the ratio of Bcl‐2 to Bax in the cortices and hippocampi of 3xTg‐AD mice and in APPswe transfected HT22 cells. Here, FGF10 is linked to Alzheimer disease.